History of meningococcal vaccines and their serological correlates of protection

被引：52
作者：
Vipond, Caroline [1 ]
Care, Rory [1 ]
Feavers, Ian M. [1 ]
机构：
[1] NIBSC, Div Bacteriol, Potters Bar EN6 3QG, Herts, England
来源：
VACCINE | 2012年 / 30卷
关键词：
Vaccine; Meningitis; Polysaccharide; Outer membrane vesicle; Serological correlate; Complement; Bactericidal antibody; Gene expression; OUTER-MEMBRANE PROTEIN; C CONJUGATE VACCINE; MENINGITIDIS GROUP-B; FACTOR-H BINDING; NEISSERIA-MENINGITIDIS; SEROGROUP-C; GROUP-A; IMMUNE-RESPONSE; VESICLE VACCINE; POLYSACCHARIDE VACCINE;
D O I：
10.1016/j.vaccine.2011.12.060
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
For over a hundred years Neisseria meningitidis has been known to be one of the major causes of bacterial meningitis. However, effective vaccines were not developed until the latter part of the 20th century. The first of these were based on purified high molecular weight capsular polysaccharides and more recently the development of glycoconjugate vaccines has made paediatric immunisation programmes possible. The prevention of group B meningococcal disease has remained a challenge throughout this period. This review charts the history of the development of meningococcal vaccines and the importance of serological correlates of protection in their evaluation. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码：B10 / B17
页数：8
相关论文
共 125 条
  • [1] DECLINE OF CHILDHOOD HAEMOPHILUS-INFLUENZAE TYPE-B (HIB) DISEASE IN THE HIB VACCINE ERA
    ADAMS, WG
    DEAVER, KA
    COCHI, SL
    PLIKAYTIS, BD
    ZELL, ER
    BROOME, CV
    WENGER, JD
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (02): : 221 - 226
  • [2] Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England
    Andrews, N
    Borrow, R
    Miller, E
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (05) : 780 - 786
  • [3] Restored functional immunogenicity of purified meningococcal PorA by incorporation into liposomes
    Arigita, C
    Kersten, GFA
    Hazendonk, T
    Hennink, WE
    Crommelin, DJA
    Jiskoot, W
    [J]. VACCINE, 2003, 21 (9-10) : 950 - 960
  • [4] PREVENTION OF MENINGOCOCCAL DISEASE BY GROUP-C POLYSACCHARIDE VACCINE
    ARTENSTEIN, MS
    GOLD, R
    ZIMMERLY, JG
    WYLE, FA
    SCHNEIDER, H
    HARKINS, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1970, 282 (08) : 417 - +
  • [5] ARTENSTEIN MS, 1975, YALE J BIOL MED, V48, P197
  • [6] Impact of meningococcal C conjugate vaccine in the UK
    Balmer, P
    Borrow, R
    Miller, E
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2002, 51 (09) : 717 - 722
  • [7] The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada
    Bettinger, Julie A.
    Scheifele, David W.
    Le Saux, Nicole
    Halperin, Scott A.
    Vaudry, Wendy
    Tsang, Raymond
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (03) : 220 - 224
  • [8] Neisseria meningitidis group B correlates of protection and assay standardization -: International meeting report Emory University, Atlanta, Georgia, United States, 16-17 march 2005
    Borrow, R.
    Carlone, G. M.
    Rosenstein, N.
    Plikaytis, B.
    Blake, M.
    Feavers, I.
    Martin, D.
    Zollinger, W.
    Robbins, J.
    Aaberge, I.
    Granoff, D. M.
    Miller, E.
    van Alphen, L.
    Poolman, J.
    Rappuoli, R.
    Danzig, L.
    Hackell, J.
    Danve, B.
    Caulfield, M.
    Lambert, S.
    Stephens, D.
    [J]. VACCINE, 2006, 24 (24) : 5093 - 5107
  • [9] Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: Reevaluation of correlates of protection
    Borrow, R
    Andrews, N
    Goldblatt, D
    Miller, E
    [J]. INFECTION AND IMMUNITY, 2001, 69 (03) : 1568 - 1573
  • [10] Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine
    Borrow, Ray
    Andrews, Nick
    Findlow, Helen
    Waight, Pauline
    Southern, Joanna
    Crowley-Luke, Annette
    Stapley, Lorraine
    England, Anna
    Findlow, Jamie
    Miller, Elizabeth
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (01) : 154 - 159
12345678910